{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["74"],"submitter":["Statlender L"],"pubmed_abstract":["<h4>Purpose</h4>Vasopressin has become an important vasopressor drug while treating a critically ill patient to maintain adequate mean arterial pressure. Diabetes insipidus (DI) is a rare syndrome characterized by the excretion of a large volume of diluted urine, inappropriate for water homeostasis. We noticed that several COVID19 patients developed excessive polyuria suggestive of DI, with a concomitant plasma sodium-level increase and/or low urine osmolality. We noticed a temporal relationship between vasopressin treatment cessation and polyuria periods. We reviewed those cases to better describe this phenomenon.<h4>Methods</h4>We retrospectively collected COVID19 ECMO patients' (from July 6, 2020, to November 30, 2021) data from the electronic medical records. By examining urine output,"],"journal":["Journal of critical care"],"pagination":["154211"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9828890"],"repository":["biostudies-literature"],"pubmed_title":["Transient diabetes insipidus in critically ill COVID19 patients."],"pmcid":["PMC9828890"],"pubmed_authors":["Singer P","Statlender L","Kagan I","Bendavid I","Kaptzon S","Hellerman M","Fishman G","Gorfil D"],"additional_accession":[]},"is_claimable":false,"name":"Transient diabetes insipidus in critically ill COVID19 patients.","description":"<h4>Purpose</h4>Vasopressin has become an important vasopressor drug while treating a critically ill patient to maintain adequate mean arterial pressure. Diabetes insipidus (DI) is a rare syndrome characterized by the excretion of a large volume of diluted urine, inappropriate for water homeostasis. We noticed that several COVID19 patients developed excessive polyuria suggestive of DI, with a concomitant plasma sodium-level increase and/or low urine osmolality. We noticed a temporal relationship between vasopressin treatment cessation and polyuria periods. We reviewed those cases to better describe this phenomenon.<h4>Methods</h4>We retrospectively collected COVID19 ECMO patients' (from July 6, 2020, to November 30, 2021) data from the electronic medical records. By examining urine output,","dates":{"release":"2023-01-01T00:00:00Z","publication":"2023 Jan","modification":"2025-04-22T19:57:51.302Z","creation":"2025-04-06T02:55:31.337Z"},"accession":"S-EPMC9828890","cross_references":{"pubmed":["36630859"],"doi":["10.1016/j.jcrc.2022.154211"]}}